Mustafa Özen
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Genetics top 5%
- Co-authors
- Michael IttmannChad J. CreightonÖmer Faruk KarataşEmre ÖzdemirDipak Kumar GiriBernard Kwabi‐AddoSen PathakNizamettin Aydın
- Topics
- MicroRNA in disease regulation (25 papers)Cancer-related molecular mechanisms research (18 papers)Circular RNAs in diseases (14 papers)
- Partner nations
- United StatesTürkiyeCanada
In The Last Decade
Mustafa Özen
89 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Molecular Biology 2.7k
- Cancer Research 1.8k
- Pulmonary and Respiratory Medicine 1.0k
- Oncology 758
- Genetics 410
Countries citing papers authored by Mustafa Özen
This map shows the geographic impact of Mustafa Özen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Özen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Özen more than expected).
Fields of papers citing papers by Mustafa Özen
This network shows the impact of papers produced by Mustafa Özen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Özen. The network helps show where Mustafa Özen may publish in the future.
Co-authorship network of co-authors of Mustafa Özen
This figure shows the co-authorship network connecting the top 25 collaborators of Mustafa Özen. A scholar is included among the top collaborators of Mustafa Özen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mustafa Özen. Mustafa Özen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 80 | |
| 3 | 35 | |
| 4 | 26 | |
| 5 | 3 | |
| 6 | 4 | |
| 7 | 22 | |
| 8 | 67 | |
| 9 | 44 | |
| 10 | 5 | |
| 11 | 47 | |
| 12 | 41 | |
| 13 | 125 | |
| 14 | 33 | |
| 15 | 4 | |
| 16 | Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. | 68 |
| 17 | 284 | |
| 18 | 45 | |
| 19 | Paclitaxel and water-soluble poly (L-glutamic acid)-paclitaxel, induce direct chromosomal abnormalities and cell death in a murine metastatic melanoma cell line. | 25 |
| 20 | 9 |
About Mustafa Özen
Mustafa Özen is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 90 papers that have together received 4.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (25 papers), Cancer-related molecular mechanisms research (18 papers) and Circular RNAs in diseases (14 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (2.7k citations) and Pulmonary and Respiratory Medicine (1.0k citations). Mustafa Özen has collaborated with scholars based in United States, Türkiye and Canada. Frequent co-authors include Michael Ittmann, Chad J. Creighton, Ömer Faruk Karataş, Emre Özdemir, Dipak Kumar Giri, Bernard Kwabi‐Addo, Sen Pathak, Nizamettin Aydın, Esra Güzel and Elnaz Pashaei. Their work appears in journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.